References
- Alestig K., Trollfors B., Andersson R., Olaisson L., Suurkula M., Norrby S. R. Ceftazidime and renal function. J Antimicrob Chemother 1984; 13: 177–182
- Ehrnström M. C. Uber febrile albuminurie. Acta Med Scand 1941; 123((Suppl))320–325
- Foord R. D. Cephaloridine, cephalothin and the kidney. J Antimicrob Chemother 1975; I((Suppl))119–133
- Gibey R., Dupond J. L., Alber D., des Floris R. L, Henry J. C. Predictive value of N-acetyl-beta-D-glucosaminidase, alanineaminopeptidase and β-microglobulin in evaluating nephrotoxicity of gentamicin. Clin Chim Acta 1981; 116: 25–34
- Harding S. M., Munro A. J., Thornton J. E., Ayrton J., Hogg M. I.J. The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers. J Antimicrob Chemother 1981; 8((Suppl B))263–272
- Hemmingsen L., Skaarup P. Urinary excretion of ten plasma proteins in patients with febrile diseases. Acta Med Scand 1977; 201: 359–364
- Linton A. L., Bailey R. R., Turnbull D. J. Relative nephrotoxicity of cephalosporin antibiotics in an animal model. Canad Med Assoc J 1972; 107: 414–416
- Luft F. C., Rankin L. I., Sloan R. S., Yum M. N. Recovery from aminoglycoside nephrotoxicity with continued drug administration. Antimicrob Ag Chemother 1978; 14: 284–287
- Mondorf A. W., Breier J., Mendus J., Scherberich J. E., Mackenrodt G., Shah P. M., Stille W., Schoeppe W. The effect of aminoglycosides on proximal tubular membranes of the human kidney. Eur J Clin Pharmacol 1978; 13: 133–142
- Norrby S. R., Burman L. Å., Linderholm H., Trollfors B. Ceftazidime: pharmacokinetics in patients and effects on renal function. J Antimicrob Chemother 1982; 10: 199–206
- Sack K., Freiesleben H., Schulz E., Marre R., Henkel W. Experimental investigations of cefuroxime in renal tolerance and therapeutic efficacy in pyelonephritis. Proc Roy Soc Med 1977; 70: 134–138
- Schardijn G., van Statius, Eps L. W., Swaak A. J.G., Kager J. C.G.M., Persijn J. P. Urinary β2-microglobulin in upper and lower urinary tract infections. Lancet 1979; i: 805–807
- Schardijn G. H., van Statius C., Eps L. W., Pauw W., Hoefnagel C., Nooyen W. J. Comparison of reliability of tests to distinguish upper from lower urinary tract infections. Brit Med J 1984; 289: 284–287
- Schentag J. J., Sutfin T. A., Plaut M. E., Jusko W. J. Early detection of aminoglycoside nephrotoxicity with urinary β2-microglobulin. J Med 1978; 9: 201–210
- Schentag J. J., Plaut M. E. Patterns of urinary β2-microglobulin excretion by patients treated with aminoglycosides. Kidney Int 1980; 17: 654–661
- Sethi K., Diamond L. H. Aminoglycoside nephrotoxicity and its predictability. Nephron 1981; 27: 265–270
- Silverblatt F., Turck M., Bulger R. Nephrotoxicity due to cephaloridine: A light and electron microscopic study in rabbits. J Infect Dis 1970; 122: 33–44
- Trollfors B., Alestig K., Krantz I., Norrby R. Quantitative nephrotoxicity of gentamicin in nontoxic doses. J Infect Dis 1980; 141: 306–310
- Trollfors B., Bergmark J., Hiesche K., Jagenburg R. Urinary alanine aminopeptidase and β2-microglobulin as measurements of aminoglycoside-associated renal impairment. Infection 1984; 12: 20–22
- Trollfors B., Norrby R., Bergmark J., Hultberg B., Linderholm H. Comparative toxicity of gentamicin and cefotetan. To be publised
- Tune B., Fernholt M. Relationship between cephaloridine and paraaminohippurate transport in the kidney. Amer J Physiol 1973; 225: 1114–1117
- Tune B. M. Relationship between the transport and toxicity of cephalosporins in the kidney. J Infect Dis 1975; 132: 189–194
- Welty J. W. Febrile albuminuria. Am J Med Sci 1937; 194: 70–75
- Wibell L., Evrin P. E. The urinary excretion of β2-microglobulin in renal disorders. Protides of the biological fluids-21st colloquium, H. Peters. Pergamon Press, Oxford and New York 1973; 519–523
- Wide L., Thoren L. Increased urinary clearance for albumin, β2-microglobulin, insulin and luteinizing hormone following surgical or accidental trauma. Scand J Clin Lab Invest 1972; 30: 275–279